The Watertown, Mass.-based company is developing an epinephrine auto-injector designed to treat severe allergic reactions.
Windgap Medical is reportedly working on a product that can withstand harsh temperatures and can be easily stored in a user’s pocket. In an interview with Allergy Eats, co-founder & CTO Brent Buchine described his company’s technology as “the next generation of epinephrine autoinjectors.”
It’s a solution that would likely be welcomed with open arms by consumers. A number of leading epinephrine auto-injector manufacturers reported shortages last year and the price of Mylan’s EpiPen has risen sharply over the last decade.
Sandoz described Symjepi as an “affordable” alternative to EpiPens but did not disclose the product’s price.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.